Chaim Lebovits, President & CEO at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 245,072 shares at $0.53 ($132K) on 2024-04-18, disclosed to the SEC on 2024-07-31.
Seasonal purchase ($132k) by President & CEO — this insider has traded BCLI in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.55 | 130,000 | $72K | 54.0% |
| 2 | $0.53 | 115,072 | $61K | 46.0% |
| Total | $0.54 avg | 245,072 | $132K | 100% |
| Filing → |